Abstract:Background and aims:<bold> </bold>Dynamic evaluation of critically ill patients is the key to predicting their outcomes. Most scores based on the Model for End-stage Liver Disease (MELD) and acute-on-chronic liver failure (ACLF) utilize point-in-time assessment. This study mainly aimed to investigate the impact of dynamic clinical course change on post-liver transplantation (LT) survival.Methods:<bold> </bold>This study included 637 adults (overall cohort) with benign end-stage liver diseases. The authors compared the MELD scores and our ACLF-based dynamic evaluation scores. Patients enrolled or transplanted with ACLF-3 were defined as the ACLF-3 cohort ( n =158). The primary outcome was 1-year mortality. Delta MELD and Delta CLIF-OF (Chronic Liver Failure-Organ Failure) represented the respective dynamic changes in liver transplant function. Discrimination was assessed using the area under the curve. A Cox regression analysis identified independent risk factors for specific organ failure and 1-year mortality.Results:<bold> </bold>Patients were grouped into three groups: the deterioration group (D), the stable group (S), and the improvement group (I). The deterioration group (Delta CLIF-OF >= 2) was more likely to receive national liver allocation ( P =0.012) but experienced longer cold ischemia time ( P =0.006) than other groups. The area under the curves for Delta CLIF-OF were 0.752 for the entire cohort and 0.767 for ACLF-3 cohorts, both superior to Delta MELD ( P <0.001 for both). Compared to the improvement group, the 1-year mortality hazard ratios (HR) of the deterioration group were 12.57 (6.72-23.48) for the overall cohort and 7.00 (3.73-13.09) for the ACLF-3 cohort. Extrahepatic organs subscore change (HR=1.783 (1.266-2.512) for neurologic; 1.653 (1.205-2.269) for circulation; 1.906 (1.324-2.743) for respiration; 1.473 (1.097-1.976) for renal) were key to transplantation outcomes in the ACLF-3 cohort. CLIF-OF at LT (HR=1.193), Delta CLIF-OF (HR=1.354), and cold ischemia time (HR=1.077) were independent risk factors of mortality for the overall cohort, while Delta CLIF-OF (HR=1.384) was the only independent risk factor for the ACLF-3 cohort. Non-ACLF-3 patients showed a higher survival rate than patients with ACLF-3 in all groups ( P =0.002 for I, P =0.005 for S, and P =0.001 for D).Conclusion:<bold> </bold>This was the first ACLF-based dynamic evaluation study. Delta CLIF-OF was a more powerful predictor of post-LT mortality than Delta MELD. Extrahepatic organ failures were core risk factors for ACLF-3 patients. CLIF-OF at LT, Delta CLIF-OF, and cold ischemia time were independent risk factors for post-LT mortality. Patients with a worse baseline condition and a deteriorating clinical course had the worst prognosis. Dynamic evaluation was important in risk stratification and recipient selection.

Assessment of liver transplant benefit and a novel strategy for liver donor allocation in acute-on-chronic liver failure

Effect of Donor Diabetes on Prognosis of Liver Transplantation in Patients with Acute-Chronic Liver Failure

Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Impact of Donor Age on Liver Transplant Outcomes in Patients with Acute-on-Chronic Liver Failure: A Cohort Study.

Liver transplantation for acute-on-chronic liver failure

Liver Transplantation in Acute-on-chronic Liver Failure Patients with High Model for End-Stage Liver Disease (MELD) Scores: a Single Center Experience of 100 Consecutive Cases.

Artificial Liver Support System Combined With Liver Transplantation In The Treatment Of Patients With Acute-On-Chronic Liver Failure

Impact of Donor Diabetes Mellitus Status on Liver Transplant Outcomes in Patients with Acute-on-chronic Liver Failure

Dynamic evaluation based on acute-on-chronic liver failure predicts survival of patients after liver transplantation: a cohort study

[Therapeutic Effect of Liver Transplantation on Acute Liver Failure].

Liver Transplantation in a Patient with Acute-on-Chronic Liver Failure Due to Traditional Chinese Medicine Intoxication Using Donation after Circulatory Death from a Renal Transplant Recipient: A Case Report.

From prognostication to therapeutics: Four key questions to accelerate the development of therapeutics for patients with acute-on-chronic liver failure

Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors.

Impact of cirrhosis-related complications on posttransplant survival in patients with acute-on-chronic liver failure

Acute-on-chronic liver failure: far to go—a review

Paving the Way to Improve Clinical Management of Acute-on-chronic Liver Failure Using International Criteria

A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure

A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation

Assessment of the Combined Effect of Plasma Exchange and Plasma Perfusion on Patients with Severe Hepatitis Awaiting Orthotopic Liver Transplantation

Efficacy of liver transplantation for acute hepatic failure: a single-center experience

Clinical outcomes and predictors in patients with acute on chronic liver failure in Southern Taiwan